Use of recombinant hematopoietic growth factors after chemotherapy and high-dose chemo-radiotherapy
Gianni, A.M.; Bregni, M.; Siena, S.; Tarella, C.
Haematologica 74(5 Suppl): 511-526
1989
ISSN/ISBN: 0390-6078 PMID: 2574136 Document Number: 326619
Document emailed within 1 workday
Related Documents
Karthaus, M.; Ganser, A. 1997: Current status of clinical indications for hematopoietic growth factors after chemo-/radiotherapy in gynecology Zentralblatt für Gynakologie 119(12): 585-596Siena, S.; Bregni, M.; Bonsi, L.; Sklenar, I.; Bagnara, G.P.; Bonadonna, G.; Gianni, A.M. 1993: Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factors Experimental Hematology 21(12): 1583-1590
Bearman, S.I.; Shpall, E.J.; Jones, R.B.; Cagnoni, P.J.; Ross, M. 1996: High-dose chemotherapy with autologous hematopoietic progenitor cell support for metastatic and high-risk primary breast cancer Seminars in Oncology 23(1 Suppl 2: 60-67
Antimi, M. 1998: High-dose chemotherapy of breast cancer with hematopoietic protection; current status and prospectives La Clinica Terapeutica 149(921): 7-9
Kotz, K.W.; Schilder, R.J. 1995: High-dose chemotherapy and hematopoietic progenitor cell support for patients with epithelial ovarian cancer Seminars in Oncology 22(3): 250-262
Wang, C.; Wang, B.M.; Li, C.Y. 1992: Effects of various recombinant human hematopoietic growth factors on proliferation of blast cells in acute myeloid leukemia in vitro Zhonghua Nei Ke Za Zhi 31(6): 350
Kaminer, L.S.; Williams, S.F.; Beschorner, J.; O'Brien, S.; Golick, J.; Bitran, J.D. 1989: High dose chemotherapy with autologous hematopoietic stem cell support in the treatment of refractory stage IV breast carcinoma Bone Marrow Transplantation 4(4): 359-362
Rosti, V.; Pedrazzoli, P.; Ponchio, L.; Zibera, C.; Novella, A.; Lucotti, C.; Della Cuna, G.R.; Cazzola, M. 1993: Effect of recombinant human erythropoietin on hematopoietic and non-hematopoietic malignant cell growth in vitro Haematologica 78(4): 208-212
Sola, C.; Mendoza, L.; Amill, B.; Mesía, R.; Rueda, A.; Alonso, M.C.; Ojeda, B.; Artigas, V.; Tugues, D.; García, J. 1995: Intensive chemotherapy with support of peripheral hematopoietic progenitor cells, mobilized with high-dose cyclophosphamide and G-CSF: fast hematologic recovery Revista Clinica Espanola 195(2): 83-88
Motoyoshi, K. 1990: Advances in hematopoietic growth factor research and bone marrow transplantation--hematopoietic stem cells and their growth factors Nihon Rinsho. Japanese Journal of Clinical Medicine 48(9): 1941-1948
Yalcin, B.; Pamir, A.; Buyukcelik, A.; Utkan, G.; Akbulut, H.; Demirkazik, A.; Icli, F. 2004: High-dose ifosfamide with hematopoietic growth factor support in advanced bone and soft tissue sarcomas Experimental Oncology 26(4): 320-325
Gaspar, N.; Boudou, P.; Haroche, J.; Wechsler, B.; Van Den Neste, E.; Hoang-Xuan, K.; Amoura, Z.; Guillevin, R.; Savatovski, J.; Azar, N.; Piette, J-Charles.; Leblond, Véronique. 2006: High-dose chemotherapy followed by autologous hematopoietic stem cell transplantation for adult histiocytic disorders with central nervous system involvement Haematologica 91(8): 1121-1125
Purdy, M.H. 1995: Positive selection and ex vivo expansion of hematopoietic progenitors as autografts for high-dose chemotherapy, potential importance in patients with bone metastases Canadian Journal of Oncology 5 Suppl. 1: 63-68
Zhou, J.C. 1991: Randomized trial of combined chemotherapy including high dose cisplatin and radiotherapy for esophageal cancer Zhonghua Zhong Liu Za Zhi 13(4): 291-294
Rühl, U. 2000: Consolidation radiotherapy after high-dose chemotherapy and autologous bone marrow transplantation in patients with advanced breast cancer Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 176(4): 196-197
Mitsuhashi, T.; Miyazaki, T.; Sakimoto, T.; Kubo, N.; Ishiguro, T.; Okada, N.; Yokoyama, M.; Ishibashi, K.; Matsuki, M.; Takahashi, T.; Ishida, H. 2008: Clinical significance of chemotherapy and chemo-radiotherapy in patients with metastatic esophageal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(12): 1999-2001
Bertucci, F.; Viens, P.; Gravis, G.; Blaise, D.; Faucher, C.; Oziel-Taoeb, S.; Bardou, V.J.; Jacquemier, J.; Delpero, J.R.; Maraninchi, D. 1999: High-dose chemotherapy with hematopoietic stem cell support in patients with advanced epithelial ovarian cancer: analysis of 67 patients treated in a single institution Anticancer Research 19(2b): 1455-1461
Thomas, X.; Campos, L.; Bonnier, S.; Troncy, J.; Guyotat, D.; Fière, D. 1990: Response of hematopoietic precursor cells to hematopoietic growth factors in the myelodysplastic syndromes Nouvelle Revue Francaise d'Hematologie 32(5): 345-347
Revazova, E.S. 1981: Effect of chemo- and radiotherapy on the growth of human strains of respiratory and excretory organ tumors transplanted in athymic mice Biulleten' Eksperimental'noi Biologii i Meditsiny 92(11): 593-596
Reerink, O.; Karrenbeld, A.; Plukker, J.T.M.; Verschueren, Ré.C.J.; Szabó, B.G.; Sluiter, W.J.; Hospers, G.A.P.; Mulder, N.H. 2004: Molecular prognostic factors in locally irresectable rectal cancer treated preoperatively by chemo-radiotherapy Anticancer Research 24(2c): 1217-1221